Top Markets
#1 Black Phoenix Black Phoenix +736.57%
#2 Islamic Coin Islamic Coin +146.17%
#3 THORChain THORChain +26.71%
#4 MiL.k Alliance MiL.k Alliance +26.65%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.17%
#6 THORChain Yield THORChain Yield +20.24%
#7 Bless Bless +19.93%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.36%
#9 TENDIES TENDIES +14.32%
#10 Tutorial Tutorial +12.78%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Healthcare
Stock price history for Aerovate Therapeutics, Inc. (AVTE)
Highest end of day price: $92.05 on 2025-04-01

Lowest end of day price: $799.05 on 2021-06-01
Stock price history of Aerovate Therapeutics, Inc. from 2021 to 2026
Annual Stock Price Performance
Year Performance
2025 1.25%
2024 -86.27%
2023 -23.84%
2022 125.16%
2021 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $549.38 41.20%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 47.75%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $148.35 491.02%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $760.31 6.50%
CH